• Schedule 13D/G History

Hoche Partners Pharma Holding S.A. - Significant Ownership

Signature - Title
Hoche Partners Pharma Holding S.A. - Roman Sokolowski/Director
Location
Luxembourg, Luxembourg
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Hoche Partners Pharma Holding S.A..

Significant Ownership of Hoche Partners Pharma Holding S.A.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PROCF Procaps Group, S.A. Ordinary Shares, nominal value of $0.01 per share 84.38% $2.72B 2.08B Hoche Partners Pharma Holding S.A. Apr 16, 2025

Schedules 13D/G Reported by Hoche Partners Pharma Holding S.A.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.